Efficacy of fluticasone metered-dose inhaler and dry powder inhaler for pediatric asthma

Pediatrics International

Volumn 50, Issue 1, 2008, Pages 103-108

  Miyahara, Hiroaki ^a   Korematsu, Seigo ^a   Nagakura, Tomokazu ^a   Izumi, Tatsuro ^a  

^a OITA UNIVERSITY   (Japan)

Author keywords

Adolescent; Bronchial asthma; Fluticasone; Spirometry

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; FLUTICASONE PROPIONATE; STEROID; THEOPHYLLINE;

ADOLESCENT; AEROSOL; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DOSAGE FORM COMPARISON; DRUG EFFICACY; DRY POWDER; FEMALE; FORCED EXPIRATORY VOLUME; HOARSENESS; HUMAN; INFECTION; INHALATION SPACER; LUNG FUNCTION TEST; MALE; METERED DOSE INHALER; MODERATE PERSISTENT ASTHMA; MOON FACE; OBESITY; PEAK EXPIRATORY FLOW; POWDER INHALER; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SPIROMETRY; THRUSH;

ADMINISTRATION, INHALATION; ADOLESCENT; ANDROSTADIENES; ASTHMA; BRONCHODILATOR AGENTS; CHILD; DRUG DELIVERY SYSTEMS; HUMANS; METERED DOSE INHALERS; POWDERS;

EID: 39049119848     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2007.02523.x     Document Type: Article

References (10)

1. Nishima S, Furusho K. New pediatric guideline for the treatment and management of bronchial asthma in Japan. Pediatr. Int. 2003 45 : 759 66.
2. Malton A, Sumby BS, Smith IJ. A comparison of in vitro drug delivery from two multidose powder inhalation devices. Eur. J. Clin. Res. 1995 7 : 177 93.
3. Vaswani SK, Creticos PS. Metered dose inhaler. Ann. Allergy Asthma Immunol. 1998 80 : 11 19.
4. Ohbayashi H. The clinical evaluation of the acceptance of fluticasone propionate Diskus by older Japanese patients with bronchial asthma. Allergol. Int. 2005 3 : 411 18.
5. Ahrens RC. The role of the MDI and DPI in pediatric patients: "children are not just miniature adults". Respir. Care 2005 50 : 1323 30.
6. Geller DE. Comparing clinical features of the nebulizer, metered-dose inhaler, and dry powder inhaler. Respir. Care 2005 50 : 1313 22.
7. Langley SJ, Holden J, Derham A, Hedgeland P, Sharma RK, Woodcock A. Fluticasone propionate via diskhaler or hydrofluoroalkane-134a metered-dose inhaler on methacholine-induced airway hyperresponsiveness. Chest 2002 122 : 806 11.
8. Thorsson L, Edsbäcker S, Källen A, Löfdahl CG. Pharmacokinetics and systemic activity of fluticasone via Diskus and pMDI, and of budesonide via Turbuhaler. Br. J. Clin. Pharmacol. 2001 52 : 529 38.
9. Goldberg S, Algur N, Levi M et al. Adrenal suppression among asthmatic children receiving chronic therapy with inhaled corticosteroid with and without spacer device. Ann. Allergy Asthma Immunol. 1996 76 : 234 8.
10. Szefler SJ, Boushey HA, Pearlman DS et al. Time to onset of effect of fluticasone propionate in patients with asthma. J. Allergy Clin. Immunol. 1999 103 : 780 88.